- Home
- / ZHEJIANG STARRY PHARMACEUTICAL
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ZHEJIANG STARRY PHARMACEUTICAL financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥9.1
2024-10-29
Market Capitalization
¥3.9 B
2024-10-29
Revenue
¥2 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 867.2M | 1.3B | 1.3B | 1.9B | 1.9B | 2.0B | 2.0B |
| Cost of goods sold | 530.1M | 749.7M | 765.7M | 1.3B | 1.6B | 1.7B | 1.9B |
| Gross profit | 347.9M | 545.8M | 588.3M | 732.4M | 497.9M | 514.9M | 437.5M |
| Gross profit margin, % | 42.9% | 43.8% | 39.4% | 26.9% | 26.0% | 21.9% | |
| Operating expense total | (34.3M) | 101.3M | 113.8M | 84.5M | 188.4M | 173.7M | 159.9M |
| Depreciation and amortization | 207.6M | 135.4M | 126.2M | 192.5M | 273.6M | 181.8M | 228.4M |
| EBITDA | 383.9M | 447.6M | 476.5M | 649.8M | 307.8M | 331.2M | 271.0M |
| EBITDA margin, % | 35.2% | 35.5% | 35.0% | 16.6% | 16.8% | 13.6% | |
| EBIT | 170.1M | 311.3M | 369.7M | 459.9M | 37.5M | 156.0M | 57.1M |
| EBIT margin, % | 24.5% | 27.5% | 24.8% | 2.0% | 7.9% | 2.9% | |
| Interest income | 3.0M | 2.0M | 3.9M | 5.7M | 9.7M | 7.5M | 8.4M |
| Interest expense | 65.0M | 82.6M | 92.0M | 73.8M | 92.6M | 102.6M | 96.2M |
| Pre tax profit | 118.7M | 221.9M | 303.7M | 395.4M | (65.4M) | 45.4M | (57.2M) |
| Income tax expense | 23.2M | 39.0M | 50.1M | 65.6M | 6.5M | 800.0K | (8.1M) |
| Net Income | 95.5M | 182.9M | 253.6M | 329.8M | (71.9M) | 44.6M | (49.1M) |